Increased plasma levels of angiogenin and the risk of bladder carcinoma: From initiation to recurrence

Cancer

Volumn 104, Issue 1, 2005, Pages 30-35

  Zhao, Hua ^a   Grossman, H Barton ^a   Delclos, George L ^b   Hwang, Lu Yu ^b   Troisi, Catherine L ^b   Chamberlain, Robert M ^a   Chenoweth, Marsha A ^a   Zhang, Huifeng ^a   Spitz, Margaret R ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Angiogenin; Bladder carcinoma; Recurrence

Indexed keywords

ANGIOGENIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; TUMOR RECURRENCE;

CARCINOMA; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RIBONUCLEASE, PANCREATIC; RISK; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 20544471882     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21136     Document Type: Article

References (32)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
3. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1995;1:149-153.
4. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature. 1987;329:630-632.
5. Yamamoto Y, Toi M, Kondo S, et al. Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res. 1996;2:821-826.
6. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 1994;86:356-361.
7. Wunderlich H, Steiner T, Junker U, Knofel B, Schlichter A, Schubert J. Serum transforming growth factor-beta in patients with renal cell carcinoma. J Urol. 1997;157:1602-1603.
8. Leitzel K, Bryce W, Tomita J, et al. Elevated plasma platelet-derived growth factor B-chain levels in cancer patients. Cancer Res. 1991;51:4149-4154.
9. Shimoyama S, Gansauge F, Gansauge S, Negri G, Oohara T, Beger HG. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness. Cancer Res. 1996;56:2703-2706.
10. Strydom DJ, Fett JW, Lobb RR, et al. Amino acid sequence of human tumor derived angiogenin. Biochemistry. 1985;24:5486-5494.
11. Kurachi K, Davie EW, Strydom DJ, Riordan JF, Vallee BL. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry. 1985;24:5494-5498.
12. D'Alessio G, Di Donato A, Parente A, Piccoli R. Seminal RNase: a unique member of the ribonuclease superfamily. Trends Biochem Sci. 1991;16:104-106.
13. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochemistry. 1986;25:3527-3532.
14. Shapiro R, Strydom DJ, Olson KA, Vallee BL. Isolation of angiogenin from normal human plasma. Biochemistry. 1987;26:5141-5146.
15. Hu GF, Riordan JF. Angiogenin enhances actin acceleration of plasminogen activation. Biochem Biophys Res Commun. 1993;197:682-687.
16. Badet J, Soncin F, Guitton JD, Lamare O, Cartwright T, Barritault D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci USA. 1989;86:8427-8431.
17. Chopra V, Dinh TV, Hannigan EV. Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol. 1997;123:167-172.
18. Olson KA, Fett JW, French TC, Key ME, Vallee BL. Angiogenin antagonists prevent tumor growth in vivo. Proc Natl Acad Sci USA. 1995;92:442-446.
19. Sheen-Chen S, Eng H, Chen W, Chou F, Chen H. Serum level of angiogenin in breast cancer. Anticancer Res. 2000;20:4769-4772.
20. Bodner-Adler B, Hefler L, Bodner K, et al. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN). Anticancer Res. 2000;21:809-812.
21. Wechsel HW, Bichler K, Feil G, Loeser W, Lahme S, Petri E. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res. 1999;19:1537-1540.
22. Miyake H, Hara I, Yamanaka K, Gonji K, Arakawa S, Kamidono S. Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients in related to disease progression and recurrence. Cancer. 1999;86:316-324.
23. Shimoyama S, Yamasaki K, Kawahara M, Kaminishi M. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression. Clin Cancer Res. 1999;5:1125-1130.
24. Shimoyama S, Kaminishi M. Increased angiogenin expression in gastric cancer correlated with cancer progression. J Cancer Res Clin Oncol. 2000;126:468-474.
25. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001;19:577-583.
26. Chopin DK, Caruelle JP, Colombel M, et al. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol. 1993;150:1126-1130.
27. Hudmon KS, Honn SE, Jiang H, et al. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:565-571.
28. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1-the analysis of case-control studies. IARC Sci Publ. 1980;32:5-338.
29. Piccoli R, Olson KA, Vallee BL, Fett JW. Chimeric anti-angiogenin antibody cAb26-2F inhibits the formation of human breast cancer xenografts in athymic mice. Proc Natl Acad Sci USA. 1998;95:4579-4583.
30. Street JT, Wang JH, Wu QD, Wakai A, McGuinness A, Redmond HP. The angiogenic response to skeletal injury is preserved in the elderly. J Orthop Res. 2001;19:1057-1066.
31. Weinsaft JW, Edelberg JM. Aging-associated changes in vascular activity: a potential link to geriatric cardiovascular disease. Am J Geriatr Cardiol. 2001;10:348-354.
32. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 1996;2:689-692.